Cargando…

Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR

Detalles Bibliográficos
Autores principales:	Pelcovits, Ari, Pandita, Aakriti, Farmakiotis, Dimitrios, Egan, Pamela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664342/ https://www.ncbi.nlm.nih.gov/pubmed/33285314 http://dx.doi.org/10.1016/j.leukres.2020.106473

Ejemplares similares

Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies
por: Youk, Jeonghwan, et al.
Publicado: (2017)

Predictors of severity and mortality among patients hospitalized with COVID-19 in Rhode Island
por: Pandita, Aakriti, et al.
Publicado: (2021)

Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
por: McDaniel, Jessica M., et al.
Publicado: (2012)

Locoregional gastric cancer: a narrative review of multidisciplinary management
por: Pelcovits, Ari, et al.
Publicado: (2020)

530. COVID-19 in kidney transplant recipients: Single-center experience and case-control study
por: Hardesty, Anna, et al.
Publicado: (2020)

Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer
por: Verma, Rashmi, et al.
Publicado: (2016)

Squamous Cell Carcinoma of the Thyroid as a Result of Anaplastic Transformation from BRAF-Positive Papillary Thyroid Cancer
por: Basnet, Alina, et al.
Publicado: (2017)

Chemotherapy-related infectious complications in patients with Hematologic malignancies
por: Rusu, Raluca-Ana, et al.
Publicado: (2018)

Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies
por: Orsini, Paola, et al.
Publicado: (2018)

Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies
por: Coccaro, Nicoletta, et al.
Publicado: (2020)

The Neutrophil-Lymphocyte Ratio Is Positively Correlated with Aggression in Schizophrenia
por: Tong, Zhu, et al.
Publicado: (2022)

Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies
por: Kuter, David J.
Publicado: (2022)

Disseminated Mucormycosis with Positive Aspergillus Galactomannan
por: Kitmiridou, Despoina, et al.
Publicado: (2018)

Clinical Characteristics and Outcomes of Hematologic Malignancy Patients with Clostridium difficile Toxin EIA vs. PCR Positive Test Results
por: Ziegler, Matthew, et al.
Publicado: (2017)

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD
por: He, Fiona, et al.
Publicado: (2016)

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies
por: Bartlett, Nancy L, et al.
Publicado: (2014)

Lessons from next-generation sequencing analysis in hematological malignancies
por: Braggio, E, et al.
Publicado: (2013)

Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool
por: Galimberti, Sara, et al.
Publicado: (2022)

Challenges and controversies in the treatment of spinal tuberculosis
por: Pandita, Aakriti, et al.
Publicado: (2020)

The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review
por: Stefaniuk, Paulina, et al.
Publicado: (2020)

The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies
por: Yağcı, Münci, et al.
Publicado: (2015)

Pulmonary Infectious Complications in Children with Hematologic Malignancies and Chemotherapy-Induced Neutropenia
por: Voulgaridou, Aikaterini, et al.
Publicado: (2020)

Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
por: Pelcovits, Ari, et al.
Publicado: (2023)

Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study
por: Hardesty, Anna, et al.
Publicado: (2021)

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies
por: Pavletic, ZS, et al.
Publicado: (1998)

Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
por: Allegra, Alessandro, et al.
Publicado: (2021)

T-Cell Depleted Haploidentical Transplantation in Children With Hematological Malignancies: A Comparison Between CD3+/CD19+ and TCRαβ+/CD19+ Depletion Platforms
por: Gonzalez-Vicent, Marta, et al.
Publicado: (2022)

Aggressive periodontitis: A clinico-hematological appraisal
por: Kundu, Debabrata, et al.
Publicado: (2014)

Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies
por: Markouli, Mariam, et al.
Publicado: (2022)

Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience
por: Liseth, Knut, et al.
Publicado: (2010)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
por: Álvarez, José C., et al.
Publicado: (2021)

The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies
por: Shaw, Jaime L., et al.
Publicado: (2021)

Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review
por: Lv, Xiaoli, et al.
Publicado: (2022)

Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia
por: Jin, Annie, et al.
Publicado: (2019)

Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma
por: Akhtar, Saad, et al.
Publicado: (2021)

Kinetics of blood neutrophil and lymphocyte count in critically ill neutropenic patients with hematological malignancies
por: Van de Louw, Andry
Publicado: (2021)

Nanomedicine approaches for treatment of hematologic and oncologic malignancies
por: Nteli, Polyxeni, et al.
Publicado: (2022)

Ulcerative Colitis in Hematological Malignancies: Paraneoplastic Manifestation or Coincidental Bystander?
por: Christodoulidis, Gregorios, et al.
Publicado: (2020)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dbehr8ahvmmgg3ehk8pqoopqjj